New Key Statistics Module, Z-Score and F-Score
NAS:MRSN Key Ratios
Market Cap $ M | 349.35 |
Enterprise Value $ M | 213.93 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 9.29 |
Price/Sales | 10.07 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 36.00 |
EPS (TTM) $ | -1.50 |
Beneish M-Score | -2.99 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -2.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.28 |
EV-to-EBITDA | -1.29 |
PEG | -- |
Shares Outstanding M | 121.30 |
Net Margin (%) | -465.80 |
Operating Margin % | -463.86 |
Pre-tax Margin (%) | -465.80 |
Quick Ratio | 3.36 |
Current Ratio | 3.36 |
ROA % (ttm) | -60.00 |
ROE % (ttm) | -256.03 |
ROIC % (ttm) | -388.07 |
Dividend Yield % | -- |
Altman Z-Score | -5.37 |
MRSN Number of Guru Trades
MRSN Volume of Guru Trades
Gurus Latest Trades with NAS:MRSN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MRSN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Mersana Therapeutics Inc Insider Transactions
No Available Data
News about NAS:MRSN
Total 0- 1